Brueckl W M, Limmert T, Brabletz T, Guenther K, Jung A, Hermann K, Wiest G H, Kirchner T, Hohenberger W, Hahn E G, Wein A
Department of Internal Medicine I, University of Erlangen-Nuremberg, Krankenhausstr, 12, 91054 Erlangen, Germany.
Anticancer Res. 2000 Nov-Dec;20(6C):4727-32.
Hereditary non-polyposis colorectal cancer (HNPCC) patients frequently develop synchronous colorectal cancer (SCRC) which also occurs sporadically in other patients. Recent studies on microsatellite instability (MSI) in sporadic SCRC diverge completely in their findings (0%-100%). In the present study MSI and mismatch repair (MMR) proteins were evaluated according to standardised criteria (exclusion of a family history, MSI analysed according to NCI recommendations)
Paraffin embedded sections of SCRC of 30 patients were evaluated for MSI and the loss of protein expression of hMLH1 and hMSH2.
3 out of 30 (10%) patients exhibited MSI-H which 5 out of 30 (17%) showed MSI-L. Loss of protein expression of either hMLH1 or hMSH2 was found in all cases of MSI-H and none of the MSI-L cancers.
MSI is found in sporadic cases of SCRC to about the same extent as it is mentioned in the literature on sporadic single colorectal cancers. Immunohistochemistry with mismatch repair proteins could be used as a pre-screening for MMR deficiency in sporadic SCRC.
遗传性非息肉病性结直肠癌(HNPCC)患者常发生同时性结直肠癌(SCRC),散发性SCRC也见于其他患者。近期关于散发性SCRC微卫星不稳定性(MSI)的研究结果完全不同(0%-100%)。在本研究中,根据标准化标准(排除家族史,按照美国国立癌症研究所(NCI)建议分析MSI)对MSI和错配修复(MMR)蛋白进行评估。
对30例患者的SCRC石蜡包埋切片进行MSI评估以及hMLH1和hMSH2蛋白表达缺失情况评估。
30例患者中有3例(10%)表现为高度微卫星不稳定(MSI-H),5例(17%)表现为低度微卫星不稳定(MSI-L)。在所有MSI-H病例中均发现hMLH1或hMSH2蛋白表达缺失,而MSI-L的癌症病例中均未发现。
散发性SCRC病例中MSI的发生率与散发性单发性结直肠癌文献中提及的发生率大致相同。错配修复蛋白免疫组化可用于散发性SCRC错配修复缺陷的初步筛查。